This is not just another tool to image cancer. The probe is a two-for-one: detect cancer and distinguish one type from another. Together, they develop a cancer fingerprint.
Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology—a sugar-transporting biosensor—researchers at Michigan Technological University hope to reduce that timeframe down to minutes.
A collaborative team of chemists and engineers from Michigan Tech lays the groundwork for this vision in two new papers. In the Royal Society of Chemistry’s journal Chemical Communication (DOI: 10.1039/c7cc09809j), the team explains the basic science behind multicolor probes that enable targeting of a cancer-relevant fructose transporter, delving into the image-based detection of cancer cells. In the journal Biosensors (DOI: 10.3390/bios8020039), the team addresses applications for breast cancer detection and differentiating nonmalignant, pre-malignant and malignant cancer cells.
GLUT5 transports fructose and cancer loves sugar
Two Michigan Tech researchers collaborated on the studies. Marina Tanasova, assistant professor of chemistry, and Smitha Rao, assistant professor of biomedical engineering, turned a 10-minute office meeting into a two-year collaboration built on a tiny fluorescent probe that seeks out the fructose transporter named GLUT5.
Cells need carbohydrates; facilitative glucose transporters (GLUTs) bring nutrients in and out of cells. When metabolic swings kick in—say, from cancer development—the overall make-up of GLUTs change so that more or less GLUTs are active. Fructose transporters like GLUT5 are of particular interest because of the direct connection between fructose uptake and cancer development, which also changes as cancer progresses and becomes malignant.
In their Chemical Communications paper, Tanasova and Rao’s team report on the design and validation of the fluorescent probes, called ManCous, to observe GLUT5 activity in a cell. They document the multicolored fluorescence that distinguishes GLUT5-rich cells from those deficient in GLUT5. The follow up Biosensors paper provides a proof-of-principle use of these probes as tools to assess and compare GLUT5 and metabolic activity of different cell types, including normal cells and different cancer subtypes.
“We came closer to a basic screening of cells’ GLUT composition—one that both detects cancer and distinguishes type,” Tanasova says, adding that while the concept is elegant, developing the technology is not easy. “From basic science to application, there is a lot of transformation that has to happen.”
Engineering better cancer detection takes collaboration
By better understanding the science behind sugar transporters, the team is more equipped to build technology that captures an accurate and precise GLUT fingerprint of cancerous cells.
“This probe is like a Swiss army knife,” Rao says, explaining that cancer detection is not the only use for the probe. “The more we learn about cancer through these probes, the more opportunities we have to apply them—which means more chances to treat different cancers, hopefully cure them, and at least prevent their spread and maximize drug delivery.”
What makes the probe so versatile is its ability to not only seek out and highlight cancer cells, but also to reveal the metabolic nuances of different stages of cancer development. While cancer generally gobbles up fructose, the GLUT5 and metabolic activity of nonmalignant, pre-malignant and malignant breast cancer cells do vary, which is what Rao, Tanasova and their team explored in the Biosensors paper. They found that ManCou probes allow for parallel analysis and quantification of GLUT5 and metabolic activity of cells just after a 10-minute incubation period. The notable differences in fluorescence intensity observed between normal cells and cancer cells, as well as different cancer types, provide important points of differentiation between different cell types and make these probes promising tools for cancer detection and diagnostics.
The Latest on: Cancer fingerprint
via Google News
The Latest on: Cancer fingerprint
- Charles Sargent dies at 73 after cancer battle on November 13, 2018 at 10:00 am
Sargent had battled with skin cancer in previous years ... There are few places in Williamson County that does not have his fingerprint on it in some way. Our hearts are with his wife, Nancy and his c... […]
- Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting on November 9, 2018 at 4:00 am
Neon Therapeutics is a clinical-stage immuno-oncology company and a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune ... […]
- A prognostic model may predict survival in African-American women with breast cancer on November 1, 2018 at 9:20 pm
"We wanted to identify a fingerprint that could stratify African-American breast cancer patients with different prognostic risks." Utilizing data from The Cancer Proteome Atlas (TCPA), Bhattarai and c... […]
- New technique brings MR fingerprinting to breast imaging on November 1, 2018 at 8:57 am
MR fingerprinting has helped researchers study prostate cancer and brain tumors, the authors noted, but not breast tissue. “To our knowledge, the development of an MR fingerprinting approach for breas... […]
- Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and more on October 16, 2018 at 11:56 am
GW Pharma is developing Epidiolex for two other medical conditions, and has other products in clinical trials for autism spectrum disorders, the aggressive cancer glioblastoma ... plants “to have a sp... […]
- New tech uses product 'fingerprints' to detect counterfeits on October 8, 2018 at 7:27 am
Jack Ma, founder and executive chairman of Alibaba, has called counterfeits the "cancer" of the Chinese e-commerce site ... according to Entrupy's website. The fingerprint cloud technology is another ... […]
- Saudi Cancer Society launches ‘Pink Fingerprints’ awareness campaign on October 1, 2018 at 1:26 pm
RIYADH: The Saudi Cancer Society launched an awareness campaign on Monday to combat breast cancer under the name “Pink Fingerprints,” and through the Abdul Latif Jameel Center for Breast Cancer Early ... […]
- GLUT5 fluorescent probe fingerprints cancer cells on April 19, 2018 at 10:04 am
The ManCou multicolored fluorescent probe glows different colors and different intensities depending on a cancer cell's type and malignancy. Credit: Tanasova, Rao/Michigan Tech Determining the presenc... […]
- GLUT5 fluorescent probe fingerprints cancer cells on April 19, 2018 at 8:12 am
Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology--a sugar-tran... […]
via Bing News